101 related articles for article (PubMed ID: 16807138)
1. Analysis of mutagenic V(D)J recombinase mediated mutations at the HPRT locus as an in vivo model for studying rearrangements with leukemogenic potential in children.
Finette BA
DNA Repair (Amst); 2006 Sep; 5(9-10):1049-64. PubMed ID: 16807138
[TBL] [Abstract][Full Text] [Related]
2. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children.
Finette BA; Poseno T; Albertini RJ
Cancer Res; 1996 Mar; 56(6):1405-12. PubMed ID: 8640832
[TBL] [Abstract][Full Text] [Related]
3. V(D)J recombinase mediated inter-chromosomal HPRT alterations at cryptic recombination signal sequences in peripheral human T cells.
Messier TL; O'Neill JP; Finette BA
Hum Mutat; 2006 Aug; 27(8):829. PubMed ID: 16835902
[TBL] [Abstract][Full Text] [Related]
4. Gestational age and gender-specific in utero V(D)J recombinase-mediated deletions.
Yoshioka M; O'Neill JP; Vacek PM; Finette BA
Cancer Res; 2001 Apr; 61(8):3432-8. PubMed ID: 11309304
[TBL] [Abstract][Full Text] [Related]
5. V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T-lymphocytes.
Fuscoe JC; Zimmerman LJ; Lippert MJ; Nicklas JA; O'Neill JP; Albertini RJ
Cancer Res; 1991 Nov; 51(21):6001-5. PubMed ID: 1933863
[TBL] [Abstract][Full Text] [Related]
6. V(D)J targeting mistakes occur at low frequency in acute lymphoblastic leukemia.
Vanura K; Vrsalovic MM; Le T; Marculescu R; Kusec R; Jäger U; Nadel B
Genes Chromosomes Cancer; 2009 Aug; 48(8):725-36. PubMed ID: 19455608
[TBL] [Abstract][Full Text] [Related]
7. V(D)J recombinase-mediated processing of coding junctions at cryptic recombination signal sequences in peripheral T cells during human development.
Murray JM; O'Neill JP; Messier T; Rivers J; Walker VE; McGonagle B; Trombley L; Cowell LG; Kelsoe G; McBlane F; Finette BA
J Immunol; 2006 Oct; 177(8):5393-404. PubMed ID: 17015725
[TBL] [Abstract][Full Text] [Related]
8. SLP65 deficiency results in perpetual V(D)J recombinase activity in pre-B-lymphoblastic leukemia and B-cell lymphoma cells.
Sprangers M; Feldhahn N; Liedtke S; Jumaa H; Siebert R; Müschen M
Oncogene; 2006 Aug; 25(37):5180-6. PubMed ID: 16636677
[TBL] [Abstract][Full Text] [Related]
9. Analysis of genetic alterations and clonal proliferation in children treated for acute lymphocytic leukemia.
Kendall HE; Vacek PM; Rivers JL; Rice SC; Messier TL; Finette BA
Cancer Res; 2006 Sep; 66(17):8455-61. PubMed ID: 16951156
[TBL] [Abstract][Full Text] [Related]
10. A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprt.
Chen CL; Woo MH; Neale GA; Goorha RM; Fuscoe JC; Behm FG; Mathew S; Relling MV
Mutat Res; 1998 Jul; 403(1-2):113-25. PubMed ID: 9726012
[TBL] [Abstract][Full Text] [Related]
11. Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke.
Finette BA; O'Neill JP; Vacek PM; Albertini RJ
Nat Med; 1998 Oct; 4(10):1144-51. PubMed ID: 9771747
[TBL] [Abstract][Full Text] [Related]
12. V(D)J recombinase-mediated deletion of the hprt gene in T-lymphocytes from adult humans.
Fuscoe JC; Zimmerman LJ; Harrington-Brock K; Burnette L; Moore MM; Nicklas JA; O'Neill JP; Albertini RJ
Mutat Res; 1992 Sep; 283(1):13-20. PubMed ID: 1380658
[TBL] [Abstract][Full Text] [Related]
13. Accessibility control of V(D)J recombination.
Cobb RM; Oestreich KJ; Osipovich OA; Oltz EM
Adv Immunol; 2006; 91():45-109. PubMed ID: 16938538
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal translocations in childhood leukemia: natural history, mechanisms, and epidemiology.
Wiemels J
J Natl Cancer Inst Monogr; 2008; (39):87-90. PubMed ID: 18648011
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model.
Tycko B; Sklar J
Cancer Cells; 1990 Jan; 2(1):1-8. PubMed ID: 2201335
[TBL] [Abstract][Full Text] [Related]
16. The frequency of illegitimate V(D)J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapy.
Fuscoe JC; Knapp GW; Hanley NM; Setzer RW; Sandlund JT; Pui CH; Relling MV
Mutat Res; 1998 Nov; 419(1-3):107-21. PubMed ID: 9804912
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of HPRT mutant frequency in children with cancer.
Rice SC; Vacek PM; Homans AH; Kendall H; Rivers J; Messier T; Finette BA
Environ Mol Mutagen; 2003; 42(1):44-9. PubMed ID: 12874812
[TBL] [Abstract][Full Text] [Related]
18. Quantification of hprt gene deletions mediated by illegitimate V(D)J recombination in peripheral blood cells of humans.
Fuscoe JC; Vira LK; Collard DD; Moore MM
Environ Mol Mutagen; 1997; 29(1):28-35. PubMed ID: 9020304
[TBL] [Abstract][Full Text] [Related]
19. Distinct mechanisms lead to HPRT gene mutations in leukemic cells.
Lin YW; Perkins JJ; Zhang Z; Aplan PD
Genes Chromosomes Cancer; 2004 Apr; 39(4):311-23. PubMed ID: 14978792
[TBL] [Abstract][Full Text] [Related]
20. Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures.
Marculescu R; Vanura K; Montpellier B; Roulland S; Le T; Navarro JM; Jäger U; McBlane F; Nadel B
DNA Repair (Amst); 2006 Sep; 5(9-10):1246-58. PubMed ID: 16798110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
